Florida Cerebrovascular Disease Biorepository and Genomics Center

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

72 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-08-02

Study Completion Date

2026-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to create a state-wide biorepository and resource center for cerebrovascular diseases in Florida, which will include collecting medical history information and blood from subjects affected by cerebrovascular disease. The information and blood samples collected may be used in future research for the study of cerebrovascular disease and to learn about, prevent or treat other health problems.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Mayo AVC Registry and Biobank

NCT03049254

Arrhythmogenic Right Ventricular Cardiomyopathy Cardiomyopathies Heart Diseases +14 more

RECRUITING

Biomarkers of Inherited Cardiovascular Conditions

NCT02804256

Cardiomyopathy Ischemic Heart Disease

UNKNOWN

Impact of the Genetic Background as a Risk Factor for Atherosclerotic Cardiovascular Disease in the Brazilian Population

NCT05515653

Cardiovascular Diseases Acute MI Stroke +2 more

ACTIVE_NOT_RECRUITING

Vascular Disease Discovery Protocol

NCT03538639

Vascular Dysfunction Genetic Mutations Genetic Predisposition

RECRUITING

Molecular Investigation of Genetic Factors in CArDiovascular Diseases Using an BIOresource of Healthy Volunteers

NCT03038750

Cardiovascular Diseases

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebrovascular Disease Ischemic Stroke Transient Ischemic Attack Intracerebral Hemorrhage Aneurysmal Subarachnoid Hemorrhage Vascular Dementia Anoxic Brain Injury Unruptured Intracranial Aneurysm Carotid Artery Stenosis Symptomatic Asymptomatic Carotid Artery Stenosis Non-Aneurysmal Perimesencephalic Subarachnoid Haemorrhage Cerebral Venous Thrombosis Moyamoya Disease Fibromuscular Dysplasia Subarachnoid Hemorrhage Leukoaraiosis Arteriovenous Fistula Reversible Cerebral Vasoconstriction Syndrome CADASIL

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

• Affected subjects with diverse cerebrovascular conditions, including, but not limited to, ischemic stroke, transient ischemic attack (TIA), intracerebral hemorrhage (ICH), aneurysmal subarachnoid hemorrhage (aSAH), vascular dementia (VAD), anoxic brain injury, unruptured intracranial aneurysm (UIA), cavernous malformation, arteriovenous malformations (AVM), carotid and vertebral arterial dissections, symptomatic and asymptomatic cervical carotid artery atherosclerotic stenosis, non-aneurysmal perimesencephalic subarachnoid hemorrhage (naSAH), cerebral venous thrombosis (CVT), moyamoya disease, fibrosmuscular dysplasia (FMD), non-traumatic, angiography-negative subarachnoid hemorrhage, leukoaraiosis, arteriovenous fistula, reversible cerebral vasoconstriction syndrome (RCVS), and CADASIL.

Exclusion Criteria

• All patients with the following known or suspected virulent microorganisms causing an active or latent infection will be excluded from the study:

* Human immunodeficiency virus (HIV);
* Any viral hepatitis;
* West Nile virus (WNV);
* Influenza virus;
* Tuberculosis (TB);
* Any bacteremia;
* Any fungemia;
* Any prionopathy.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No